Tectonic Therapeutic (TECX) Amortization of Deferred Charges (2022 - 2026)
Tectonic Therapeutic's (TECX) quarterly Amortization of Deferred Charges came in at $496000.0 in Q1 2026, down 2.94% year-on-year from $511000.0 in Q1 2025, and down 9.49% on a QoQ basis from $548000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 5 years of Amortization of Deferred Charges data on file, last reported at $496000.0 in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges fell 2.94% year-over-year to $496000.0 in Q1 2026; TTM through Mar 2026 was $2.1 million, a 223.04% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 388.02% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $496000.0, down from $548000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for TECX reached as high as $994000.0 in Q2 2023 and fell as low as -$469000.0 in Q4 2024.
- Historically, Amortization of Deferred Charges has averaged $296866.7 across 5 years, with a median of $301000.0 in 2024.
- Across the five-year window, Amortization of Deferred Charges jumped 1083.33% in 2023 and tumbled 69.72% in 2024, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $71000.0 in 2022, then jumped by 1300.0% to $994000.0 in 2023, then sank by 147.18% to -$469000.0 in 2024, then jumped by 216.84% to $548000.0 in 2025, then dropped by 9.49% to $496000.0 in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $496000.0 in Q1 2026, $548000.0 in Q4 2025, and $535000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 496,000.00 |
| Mar 31, 2026 | 496,000.00 |
| Dec 31, 2025 | 548,000.00 |
| Dec 31, 2025 | 548,000.00 |
| Sep 30, 2025 | 535,000.00 |
| Sep 30, 2025 | 535,000.00 |
| Jun 30, 2025 | 524,000.00 |
| Jun 30, 2025 | 524,000.00 |
| Mar 31, 2025 | 511,000.00 |
| Mar 31, 2025 | 511,000.00 |
| Dec 31, 2024 | -469,000.00 |
| Dec 31, 2024 | -469,000.00 |
| Sep 30, 2024 | 308,000.00 |
| Sep 30, 2024 | 308,000.00 |
| Jun 30, 2024 | 301,000.00 |
| Jun 30, 2024 | 301,000.00 |
| Mar 31, 2024 | 294,000.00 |
| Mar 31, 2024 | 294,000.00 |
| Jun 30, 2023 | 994,000.00 |
| Jun 30, 2023 | 994,000.00 |